Glycoprotein 130 (also known as gp130, IL6ST, IL6R-beta or CD130) is a transmembrane protein which is the founding member of the class of tall cytokine receptors. It forms one subunit of the type I cytokine receptor within the IL-6 receptor family.

To return this writ and the certificate of your proceedings within 30 days after levy and service, but in no event later than 60 days after issuance of this writ. NOTICE TO DEFENDANT: The plaintiff has filed with the court a written undertaking, a copy of which is attached.

2006年1月1日 · States the court’s order to the sheriff to take and hold property that the plaintiff claims is theirs but that the defendant is wrongly keeping. Also gives defendants information …

You have the right to object to the plaintiff's undertaking on a ground specified in Code of Civil Procedure section 995.920 and in the manner provided in Code of Civil Procedure section 515.030 or to obtain redelivery of the property by filing a written undertaking of your own, in an amount equal to the plaintiff's undertaking or as determined ...

In this review, we will summarize the present knowledge about gp130 cytokines, including IL-6, LIF, CNTF, CT-1, and OSM, in adipocyte biology and metabolic activities in conditions such as obesity, cachexia, and type 2 diabetes.

2011年9月1日 · gp130 (also known as CD130) is expressed in almost all organs, including heart, kidney, spleen, liver, lung, placenta, and brain, and targeted deletion of the gp130 gene in mice results in embryonic lethality at day 12.5 (9).

Rabbit Polyclonal CD130 (gp130) antibody. Suitable for IHC-P and reacts with Mouse, Rat samples. Cited in 16 publications. Immunogen corresponding to Synthetic Peptide within Mouse Il6st aa 650-750 conjugated to Keyhole Limpet Haemocyanin.

Following IL-6 binding, the soluble IL-6R (CD126)-IL-6 complex can directly activate cells that express the signal-transducing gp130 (CD130) molecule, which mediates two distinct signals, mitogenesis by mitogen-activated protein kinase …

CD126 was detectable in 50% of either MGUS or MM patients without any change of expression during disease progression. In contrast, CD130 expression was up-regulated during tumoural expansion (43% of MM patients at diagnosis versus 88% at relapse).

CD130 is widely expressed on a variety of cell types including T cells, activated B cells, monocytes, plasma cells, and endothelia. The AM64 antibody can be used in flow cytometry, immunoprecipitation, western blot, and immunohistochemistry on frozen sections.